In addition, many human mAbs targeting the SARS-CoV-2 S protein isolated from convalescent COVID-19 patients have been reported; however, cross-binding mAbs, especially cross-neutralizing mAbs, are rarely reported (29–31), indicating that the conserved antigenic sites within the RBD may be subdominant compared to the unique sites. Here, PROS1 is linked to COVID-19.